Developing medicines with AI – Gentech teams up with Nvidia – News




Developing medicines with AI – Gentech teams up with Nvidia – News – SRF
























Skip to content

Some elements on SRF.ch only work with JavaScript activated.






Contents

  • The Roche subsidiary Gentech is teaming up with the AI ​​company Nvidia.
  • The US company Nvidia develops computer chips for artificial intelligence.
  • The cooperation is intended to advance the development of medicines thanks to improved AI research.

Nvidia’s computing expertise is intended to benefit Gentech scientists. In collaboration with Nvidia, models will be optimized and scaled, according to a statement from Roche.

The decision to work with Nvidia shows that artificial intelligence will play an important role in drug development in the future. This should become more predictable and cost-efficient in the long term.

This is Nvidia

The US company develops graphics processors and computer chips. With a market share of 80 percent, Nvidia is the market leader in computer chips for AI. The chips are designed in California and manufactured in Taiwan. A single chip of the latest generation costs around $40,000. Since the beginning of the year, Nvidia shares have risen by more than 257 percent.



Always well informed!

Receive all news highlights directly via browser push and always stay up to date.

Close


Always well informed!

Receive all news highlights directly via browser push and always stay up to date. More

Push notifications are short notices on your screen with the most important news – regardless of whether srf.ch is currently open or not. If you click on one of the notes, you will be taken to the corresponding article. You can deactivate these communications at any time. Fewer

You have already hidden this notice about activating browser push notifications several times. Do you want to hide this notice permanently or be reminded of it again in a few weeks?

Most read articles

Scroll left


Scroll right





source site-72